Resumen
Antecedentes: La inmunoterapia subcutánea acuosa a altas dosis es una ruta validada y efectiva de administración de alérgenos para el ácaro del polvo doméstico y alergias al polen.
Objetivos: Estudio de definición conceptual empleando inmunoterapia intradérmica (ITID) con alérgenos de ácaros (Dermatophagoides pteronyssinus/Dermatophagoides farinae [Dp/Df] y Blomia tropicalis [Bt]) a bajas dosis; se llevó a cabo en niños con rinitis alérgica sintomáticos a la exposición de polvo de casa.
Métodos: A ocho pacientes sin uso previo de inmunoterapia, con pruebas de punción cutánea positivas e IgE sérica específica a una mezcla de Dp/Df y Bt, se les administraron por tres meses 0.05 mL de ITID semanalmente, provenientes de una preparación fenolizada albúmino-salina y contentiva de bajas dosis de ácaros (8.3 AU= 5 ng de Dp/Df y 2.5 DBU de Bt). Los síntomas nasales (Total Nasal Symptom Score) y los faciales (Escala Análoga Visual) fueron registrados dos semanas antes del tratamiento y en el transcurso una vez a la semana. Al comienzo y al final se realizaron pruebas cutáneas diluidas y seriadas (1/100-1/1.000.000) y determinaciones de IgG4 en el suero para los alérgenos.
Resultados: Los valores de las escalas sugirieron mejoría clínica. Existió disminución significativa de los diámetros de las pápulas de las pruebas diluidas y seriadas, así como aumento de los valores de la IgG4 sérica al final del tratamiento. La ITID fue bien tolerada.
Conclusión: Si estudios ulteriores confirman los presentes hallazgos, se podría promover una mayor utilización de la inmunoterapia alérgeno-específica.Referencias
Nelson HS. Allergen immunotherapy now and in the future. Allergy Asthma Proc. 2016;37(4):268-272. DOI: 10.2500/aap.2016.37.3966
Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2012;127(Suppl 1):S1–S55. DOI: 10.1016/j.jaci.2010.09.034
Eifan AO, Calderon MA, Durham SR. Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma. Expert Opin Biol Ther. 2013;13(11):1543-1556. DOI: 10.1517/14712598.2013.844226
Jacobsen L, Wahn U, Bilo MB. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorized by level of benefit-the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy. 2012;2:8.
Des-Roches A, Paradis L, Knani J, Hejjaoui A, Dhivert H, Chanez P, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996;51(6):30 -33. DOI: 10.1111/j.1398-9995.1996.tb04643.x
Sánchez-Borges M, Fernández-Caldas E, Capriles-Hulett A, Caballero-Fonseca F. Mite hypersensitivity in patients with rhinitis and rhinosinusitis living in a tropical environment. Allergol Immunopathol (Madr). 2014;42(2):120-126. DOI: 10.1016/j.aller.2012.07.011
Capriles-Hulett A, Iraola V, Pinto H, Sánchez-Borges M, Daboín-De-Veer M, Fernández-Caldas E. Monosensitization to Blomia tropicalis: is exposure the only factor involved? J Investig Allergol Clin Immunol. 2009;19(2):165-166.
Caplin J, Capriles-Hulett A, Iraola V, Pinto H, Sánchez-Borges M, De-Los-Santos G, et al. Allergic sensitization to domestic mites in Corpus Christi, Texas. Allergy Asthma Proc. 2009;30(2):166-170. DOI: 10.2500/aap.2009.30.3209
Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Fernández-Caldas E. Mite and cockroach sensitization in allergic patients from Caracas, Venezuela. Ann Allergy Asthma Immunol. 2003;90(6):664-668. DOI: 10.1016/S1081-1206(10)61873-X
Caraballo L, Zakzuk J, Lee BW, Acevedo N, Soh JY, Sánchez-Borges M, et al. Particularities of allergy in the Tropics. World Allergy Organ J. 2016;9:20. DOI: 10.1186/s40413-016-0110-7
Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Asthma care in resource-poor settings. World Allergy Organ J. 2011;4(4):68-72. DOI: 10.1097/WOX.0b013e318213598d
Nelson H. Injection Immunotherapy for inhalant allergens. En: Middleton’s Allergy. Principles and Practice. Volume 2. EE. UU.: Saunders; 2013.
Varney VA, Gaga M, Frew AJ, Aber VR, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 1991;302(6771):265-269.
Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double blind randomized, placebo-controlled trial. Clin Exp Allergy. 2003;33(8):1076-1082. DOI: 10.1046/j.1365-2222.2003.01735.x
Franklin W, Lowell FC. Comparisons of two dosages of ragweed extract in the treatment of pollenosis. JAMA. 1967;201(12):915-917.
Van-Metre TE, Adkinson NF, Lichtenstein LM, Mardiney MR, Norman PS, Rosenberg GL, et al. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol. 1980;65(4):288-297. Disponible en: http://www.jacionline.org/article/0091-6749(80)90158-X/pdf
Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organization J. 2014;28;7(1):6. DOI: 10.1186/1939-4551-7-6
Cox L, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter. J Allergy Clin Immunol Pract. 2014;2(2):156-160. DOI: 10.1016/j.jaip.2014.01.010
Ordman D. Allergic desensitization by the intradermal route. S Afr Med J. 1961;35:617-620.
Phillips EW. Relief of hay-fever by intradermal injection of pollen extract. JAMA. 1926;86(3):182-184. DOI: 10.1001/jama.1926.02670290022008
Phillips EW. Intradermal pollen therapy during the attack. J Allergy Clin Immunol. 1933;5(1):29-36. DOI: 10.1016/S0021-8707(33)90167-7
Rotiroti G, Shamji M, Durham S, Till S. Repeated low-dose intradermal allergy injection suppresses allergen-induced cutaneous late responses. J Allergy Clin Immunol. 2012;130:918-924.
Benaim-Pinto C, Fassrainer A. Intradermal Immunotherapy in children with severe skin inflammatory reactions to Aedes aegypti and Culex quinquefasciatus mosquito bites. Int J Dermatol. 1990;29(8):600-601. DOI: 10.1111/j.1365-4362.1990.tb03479.x
Benson RL. Diagnosis and treatment of sensitization to mosquitoes. J Allergy Clin Immunol. 1933;8:47-59.
Slovick A, Douiri A, Muir R, Guerra A, Tsioulos K, Hay E, et al. Intradermal Grass Pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms. J Allergy Clin Immunol. 2017;139 (6):1830-1839. DOI: 10.1016/j.jaci.2016.09.024
Makatsori M, Pfaar O, Calderon MA. Allergen immunotherapy: clinical outcomes assesment. J Allergy Clin Immunol. 2014;2(2):123-129. DOI: 10.1016/j.jaip.2014.01.005
Bousquet PJ, Combescure C, Neukirch F, Klosser JM, Mechin H, Daures JP et al. A randomized placebo-controlled trial investigating efficacy and mechanisms of low-dose intradermal allergen immunotherapy in treatment of seasonal allergic rhinitis; Visual Analog Scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62:367-372.
Demoly P, Bousquet PJ, Mesbah K, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013;43(8):881-888. DOI: 10.1111/cea.12121
Casey N. Dying infants and no medicines: inside Venezuela’s failing hospitals. The New York Times 2016 May 15. Disponible en https://www.nytimes.com/2016/05/16/world/americas/dying-infants-and-no-medicine-inside-venezuelas-failing-hospitals.html
Oppenheimer JJ, Tankersley M, Burnett T, Engler DB, Filley WV, Larenas-Linnemann DE, et al. ACAAI´s Allergen Immunotherapy Extract Preparation. Physician Instruction Guide. EEUU: American College of Allergy, Asthma, and Immunology; 2017.
Plunkett G. Stability of major allergen proteins in extract mixes diluted in serum albumin (HSA), normal saline (NSP) or glycerin (GLY). J Allergy Clin Immunol. 2007;119(1):S105. DOI: 10.1016/j.jaci.2006.11.629
Plunkett G, Schell M. Stability of allergen extracts diluted in saline or human serum albumin solutions (abstract). Ann Allergy Asthma Immunol. 2010;105:A1-A 140.
Dreborg S. The skin prick test: methodological studies and clinical applications. Suecia: Department of Pediatrics Linköping University, 1987.
Baena-Cagnani CE, Larenas-Linnemann D, Gómez M, Díaz SG, Solé D, Borges MS, et al. Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol. 2013;111(5):415-419. DOI: 10.1016/j.anai.2013.08.011
Vaswani R, Garg A, Parikh L, Vaswani S. Non-adherence to subcutaneous allergen immunotherapy: inadequate health insurance coverage is the leading cause. Ann Allergy Asthma Immunol. 2015;115(3):241-243. DOI: 10.1016/j.anai.2015.06.018
Tabar AI, Echechipía S, García BE, Olaguibel JM, Lizaso MT, Gómez B, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules and dermatophagoides pteronyssinus. J Allergy Clin Immunol. 2005;116(1):109-118. DOI: 10.1016/j.jaci.2005.05.00538
Mauro M, Rusello M, Alesina R, Sillano V, Alessandrini A, Dama A, et al. Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one. Eur Ann Allergy Clin Immunol. 2006;38(1):31-34.
Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind placebo-controlled immunotherapy with mixed grass pollen allergoid. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol. 1998; 82(3 Pt 1):439-446. Disponible en: http://www.jacionline.org/article/0091-6749(88)90017-6/pdf
Nanda A, O'connor M, Anand M, Dreskin SC, Zhang L, Hines B, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol. 2004;114(6):1339-1344. DOI: 10.1016/j.jaci.2004.08.049
Lent AM, Harbeck R, Strand M, Sills M, Schmidt K, Efaw B, et al. Immunologic response to administration of standardized dog allergen extract at differing doses. J Allergy Clin Immunol. 2006;118(6):1249-1256. DOI: 10.1016/j.jaci.2006.07.055
Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008;121(5):1120-1125. DOI: 10.1016/j.jaci.2008.01.072
Capriles-Hulett A, Yibirin MG, Garcia A, Hurtado D. Montelukast for the high impact of asthma exacerbations in Venezuela: a practical and valid approach for Latin America? World Allergy Organ J. 2014;7(1):20. DOI: 10.1186/1939-4551-7-20
Rodríguez E, Vera V, Pérez-Puigbo A, Capriles-Hulett A, Ferro S, Manrique J, et al. Equivalence of a single saline nebulized dose of formoterol powder vs three doses of nebulized Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. Allergol Immunopathol (Madr). 2008;36(4):196-200. DOI: 10.1016/S0301-0546(08)72549-7
Capriles E, Do-Campo A, Verde O, Pluchino S, Capriles-Hulett A. Children's asthma and the third world: an approach. J Investig Allergol Clin Immunol. 2006;16(1):11-8. Disponible en: http://www.jiaci.org/issues/vol16issue01/3.pdf
Hulett AC, Yibirin MG, Brandt RB, García A, Hurtado D, Puigbó AP. Home/social environment and asthma profiles in a vulnerable community from Caracas: lessons for urban Venezuela? J Asthma. 2013;50(1):14-24. DOI: 10.3109/02770903.2012.747205
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2018 Revista Alergia México